| Identification | Back Directory | [Name]
4H-1-Benzopyran-4-one, 2,2-diethyl-2,3-dihydro-6-[3-(1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl]- | [CAS]
2256030-24-5 | [Synonyms]
TRV045
4H-1-Benzopyran-4-one, 2,2-diethyl-2,3-dihydro-6-[3-(1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl]- | [Molecular Formula]
C18H18N4O3 | [MOL File]
2256030-24-5.mol | [Molecular Weight]
338.36 |
| Hazard Information | Back Directory | [Uses]
TRV045 is a selective Sphingosine-1-phosphate subtype 1 receptor agonist with no effect on lymphocyte transport. TRV045 has antiepileptic activity[1]. | [References]
[1] de Cuba CMKE, et al. TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects. Clin Pharmacol Ther. 2024 Dec 6. DOI:10.1002/cpt.3521 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|